Peter Batushansky - 30 Oct 2025 Form 4 Insider Report for PETMED EXPRESS INC (PETS)

Reporting relationship: Director
Issuer ticker: PETS
Reported as of: 30 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Nov 2025, 16:05:16 UTC
Prior SEC filing: 11 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Peter Batushansky

Key filing fact

Peter Batushansky filed Form 4 for PETMED EXPRESS INC (PETS) on 03 Nov 2025.

Key facts

This page summarizes Peter Batushansky's Form 4 filing for PETMED EXPRESS INC (PETS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Nov 2025, 16:05.

Change

Previous filing in this sequence was filed on 11 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002064538 Primary reporting owner

Batushansky Peter

Relationship: Director
Address: C/O PETMED EXPRESS, INC., 420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Signature: /s/ Peter Batushansky
Signature date: 03 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PETS transaction

Common Stock

Award

Transaction value: $0
Shares: +33,846
Change %: +1339%
Price: $0.000000
Shares after: 36,373
Date: 30 Oct 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on October 30, 2026, subject to continued service on the Board of Directors.